KINGSVILLE, ON — February 25, 2026 — Leads & Copy —
Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) has released its unaudited condensed interim financial statements for the three and nine months ended December 31, 2025.
Net cannabis revenue for the third quarter was $2,348,797, a 40% increase from $1,676,721 in Q3 F2025. The average net sales price per gram was $1.51, compared to $1.58 in the same period last year. Net cannabis revenue for the nine months ended December 31, 2025, increased to $6,062,528 from $5,877,837 in 2025.
The company reported that the cash cost per gram sold decreased to $0.92, down from $1.03 in Q3 F2025.
Gross profit improved to $680,589 in the quarter, compared to $249,197 in Q3 F2025. Gross profit for the 2026 fiscal year totals $2,321,996, a more than 350% increase compared to the prior year. Gross margin improved to 29% (Q3 F2025: 15%).
Greenway Greenhouse Cannabis Corporation also announced that it generated positive operating income for the fourth consecutive quarter, and adjusted EBITDA was $399,738, an increase of $313,980 from $85,758 in Q3 F2025, representing the fifth consecutive quarter of positive adjusted EBITDA.
Finished goods inventory totaled 3,053,665 grams valued at $3,377,433. Cash was $1,181,770 at quarter end, and working capital (excluding amounts due to related parties) amounted to $5,819,285.
According to Jamie D’Alimonte, CEO of Greenway, the company’s quarter end cash plus the value of finished goods inventory total more than $4.5 million, giving it a healthy working capital position and inventory to support anticipated demand for its high quality product. He added that the results reflect a business that is gaining scale, improving unit economics, and strengthening strategic customer relationships.
Carl Mastronardi, President of Greenway, stated that the production team was able to reduce cash cost per gram over 10%, to $0.92 from $1.03 a year ago, demonstrating that disciplined execution in this market drives durable results. He said that moving forward, their focus remains on scaling production efficiently, optimizing yields, and enhancing product mix to ensure they continue building momentum across the platform.
The company issued an aggregate of 402,549 common shares to Abingdon Capital Corporation, an arm’s length consultant, at deemed prices between $0.15 and $0.25 per share, pursuant to its engagement letter dated June 4, 2024. The shares were issued in satisfaction of a portion of the monthly work fee owed to the Consultant as consideration for the provision of corporate-finance advisory services. All common shares issued will be subject to a hold period of four months and a day from the date of issuance in accordance with applicable CSE policies and Canadian securities laws.
Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace, headquartered in Kingsville, Ontario. More information can be found on Greenway.ca.
A copy of the interim financial statements for the quarter ended December 31, 2025 and the related Management’s Discussion and Analysis are available under the Company’s profile on www.sedarplus.ca.
Management uses a non-IFRS measure to assess the Company’s performance.
This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Source: Greenway Greenhouse Cannabis Corporation
